Linde Inc – FDA Inspection, Mar 26, 2026

Record Details

This FDA Inspection record concerns Linde Inc, with an inspection on March 26, 2026, issued by the Philadelphia District Office, covering human drugs.

Company: Linde Inc
Inspection Date: March 26, 2026
Product Type: Human Drugs
Office: Philadelphia District Office
Person: Luxuly Abraham (Issuing Officer)

View Company Profile

ID · d561ddc3-a41f-438e-a831-39e899367c5f

Inspection Facts

Inspection number: 1309404
FDA center: Human Drugs
Outcome: Form 483 issued

Other FDA inspections of Linde Inc

Date	Classification	Office	Project area
January 6, 2014	NAI	Center for Drug Evaluation and Research	Drug Quality Assurance

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Linde Inc

Date

Classification

Office

Project area

January 6, 2014

NAI

Center for Drug Evaluation and Research

Drug Quality Assurance